Stay updated with breaking news from Real World Evidence Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The global pandemic has accelerated the Food and Drug Administration’s (FDA) encouragement of real-world data (RWD) and real-world evidence (RWE) (the clinical evidence derived from...
The U.S. Food and Drug Administration (FDA) has issued a draft guidance for pharmaceutical companies, sponsors, and researchers sourcing Real World Data (RWD) from health records. As...
February 4, 2021 By Deborah Borfitz February 4, 2021 | A computer scientist at The Ohio State University (OSU) recently demonstrated the potential of artificial intelligence to crunch real-world data and emulate randomized clinical trials, speeding the pace of drug repurposing. The initial use case was focused on preventing heart failure and stroke in patients with coronary artery disease, but the model could be applied to any disease with a definable outcome, says Ping Zhang, who leads the Artificial Intelligence in Medicine Lab at OSU. Zhang is senior author of a recently pub...